Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer.

Trial Profile

Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Tegafur/uracil (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms SACURA
  • Most Recent Events

    • 06 Jun 2017 Results of a subanalysis assessing the recurrence risk factors and outcome stratification in stage II colon cancer patients, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
    • 07 Jun 2016 Primary endpoint has not been met. (Disease-free survival), as per an abstract presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 07 Jun 2016 Results of an efficacy analysis (n=1982) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top